ValuEngine upgraded shares of Express Scripts (NASDAQ:ESRX) from a hold rating to a buy rating in a research note published on Monday.
Other equities analysts have also recently issued research reports about the company. Mizuho set a $67.00 price objective on Express Scripts and gave the company a hold rating in a report on Tuesday, October 24th. Robert W. Baird restated a hold rating and set a $56.00 price objective on shares of Express Scripts in a report on Friday, September 1st. Morgan Stanley upped their target price on Express Scripts from $52.00 to $57.00 and gave the stock an underweight rating in a report on Thursday, August 10th. Royal Bank Of Canada assumed coverage on Express Scripts in a report on Tuesday, September 19th. They issued a sector perform rating and a $68.00 target price for the company. Finally, Jefferies Group reiterated a buy rating on shares of Express Scripts in a report on Thursday, October 26th. Six research analysts have rated the stock with a sell rating, eleven have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Express Scripts currently has an average rating of Hold and an average price target of $70.67.
Express Scripts (ESRX) traded up $0.73 on Monday, reaching $68.57. The company had a trading volume of 3,744,600 shares, compared to its average volume of 4,119,560. Express Scripts has a one year low of $55.80 and a one year high of $76.38. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. The stock has a market cap of $38,422.74, a PE ratio of 9.92, a P/E/G ratio of 1.00 and a beta of 0.88.
In related news, VP Phyllis S. Anderson sold 643 shares of the company’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total transaction of $40,103.91. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Woodrow A. Myers, Jr. sold 3,900 shares of the company’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $63.93, for a total value of $249,327.00. Following the transaction, the director now directly owns 11,500 shares in the company, valued at $735,195. The disclosure for this sale can be found here. Over the last three months, insiders sold 5,121 shares of company stock valued at $325,920. Corporate insiders own 0.68% of the company’s stock.
Large investors have recently made changes to their positions in the stock. Park National Corp OH increased its holdings in shares of Express Scripts by 0.3% in the second quarter. Park National Corp OH now owns 3,575 shares of the company’s stock valued at $228,000 after purchasing an additional 11 shares during the period. Parkside Financial Bank & Trust increased its holdings in shares of Express Scripts by 0.3% in the second quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock valued at $551,000 after purchasing an additional 23 shares during the period. Carroll Financial Associates Inc. increased its holdings in shares of Express Scripts by 1.0% in the second quarter. Carroll Financial Associates Inc. now owns 3,186 shares of the company’s stock valued at $203,000 after purchasing an additional 30 shares during the period. CAPROCK Group Inc. increased its holdings in shares of Express Scripts by 0.9% in the second quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock valued at $235,000 after purchasing an additional 33 shares during the period. Finally, Sandy Spring Bank increased its holdings in shares of Express Scripts by 0.6% in the second quarter. Sandy Spring Bank now owns 6,464 shares of the company’s stock valued at $413,000 after purchasing an additional 37 shares during the period. 88.44% of the stock is currently owned by institutional investors.
WARNING: This news story was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/3079820/express-scripts-esrx-raised-to-buy-at-valuengine.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.